PAX5 and leukemia: Briefly, LNCGme00432, LNCGme00344, and LNCGme00345 are known to be regulated by PAX5- and PAX5-dependent pathways, which might contribute to the differentiation of acute B lymphoblastic leukemia (B-ALL) cells and leukemia regression (Brazão et al., 2016).